Presented by Nathan Busse, Medical Physicist
Introduction
Yttrium-90 microsphere radioembolization has become an increasingly important treatment modality for liver malignancies, but establishing a new program requires careful attention to unique workflow challenges, safety protocols, and staff training considerations that differ significantly from conventional nuclear medicine procedures.
This article provides a practical overview of key topics that arise when starting a Y-90 program, drawing from real-world implementation experience. While this discussion highlights important considerations and lessons learned, those seeking comprehensive guidance should review AAPM’s Medical Physics Practice Guideline 14 (MPPG 14), which offers detailed consensus recommendations for Y-90 microsphere brachytherapy. Consider this a companion to that foundational document—a collection of practical insights focused on the operational realities and distinct challenges posed by Y-90’s physical characteristics and delivery method.
Regulatory Compliance
Reportable Medical Events
Y-90 microsphere procedures are among the most common sources of reportable medical events in radioactive material-based therapies. The NRC publishes periodic summaries of these events that serve as valuable learning tools for program development. During program planning, these summaries should be reviewed with the entire care team to identify potential failure modes and establish preventive mechanisms.
Common categories of reportable events include wrong-site administration, incorrect dose delivery (i.e. wrong vial or amount of activity), and treatment of wrong patient. Multi-layered verification procedures, timeout protocols, and clear documentation practices form the foundation of event prevention.
Staff Safety and Training
Contamination Management: A Unique Challenge
The contamination risk in Y-90 microsphere procedures deserves particular attention due to several factors that distinguish it from routine nuclear medicine work. The 64-hour half-life of Y-90 means any contamination event requires substantially more effort to remediate than short-lived isotopes like Tc-99m. Furthermore, the preparation procedure itself, repeatedly drawing from a vial using a long, flexible syringe, presents inherent contamination risks in the hot lab environment.
The physical properties of microspheres add another layer of complexity. Unlike liquid radiopharmaceuticals, these spherical particles can roll, bounce, and embed themselves in surfaces and equipment. This behavior makes containment and cleanup considerably more challenging than traditional spills.
Contamination Prevention Protocols
Effective contamination control begins with proper preparation techniques:
- Use chux or other absorbent materials in hot lab areas
- Require double-gloving for all personnel handling Y-90 materials
- Use arm guards or long sleeved clothing during preparation procedures
- Conduct regular contamination surveys of work areas
The infusion room requires similar attention. Floor protection with absorbent pads, towel draping of equipment and surfaces, and shoe covers for all personnel should be standard practice. These measures serve dual purposes: preventing contamination and facilitating cleanup should a spill occur.
Addressing Knowledge Gaps
A fundamental challenge in Y-90 programs is that procedures occur in interventional radiology suites, where staff have extensive experience with radiation safety in the context of fluoroscopy but may have limited exposure to radioactive material safety principles. This creates specific training needs:
- Radioactive material handling fundamentals
- Contamination prevention and response procedures
- Understanding of radiation exposure from sealed vs. unsealed sources
- Patient care protocols in the presence of retained radioactivity
- Emergency response procedures
Practical Exposure Management
The anatomical distribution of Y-90 microspheres creates an asymmetric radiation field around treated patients. Activity concentrated in the liver results in significantly higher exposure rates on the patient’s right side compared to the left. This geometric relationship provides a simple but highly effective exposure reduction strategy: conducting all post-procedure patient care from the patient’s left side reduces staff exposure to near-background levels.
For procedures and monitoring that must occur on the right side, maintaining distance of even a few feet dramatically reduces exposure rates.
Pregnant Staff Considerations
Dose levels from Y-90 patients do not categorically prohibit pregnant staff from participating in patient care. However, many institutions elect to implement administrative policies that exclude pregnant staff from Y-90 procedures, not as a regulatory requirement but as a measure to reduce concerns and simplify dose monitoring. This decision should be made at the institutional level with input from radiation safety officers and consideration of staffing implications.
Post-Treatment Imaging
While not mandated by regulation, post-treatment imaging provides valuable quality assurance and safety verification. Imaging confirms the intended distribution of microspheres and can identify unexpected deposition patterns that might indicate technical complications or anatomical variations affecting delivery.
Imaging Approaches
Qualitative Bremsstrahlung Imaging: The most common approach involves planar imaging that, despite relatively poor image quality, provides sufficient information to verify general distribution patterns, confirming, for instance, that activity delivered to the left lobe remained in the left lobe.
Quantitative Imaging: SPECT and PET imaging modalities offer more sophisticated dosimetric assessment capabilities. While less commonly implemented, these techniques provide detailed activity distribution data that can inform treatment planning for subsequent therapies or research applications.
Patient Management
Discharge Instructions
Y-90 microsphere therapy offers significantly simpler discharge instructions compared to other radiopharmaceutical therapies. Unlike I-131 therapy, which requires extensive precautions around bodily fluid excretion, Y-90 microspheres remain permanently implanted in the liver. This eliminates concerns about contamination from urine, saliva, sweat, or other excretions.
The primary consideration is the patient as a source of radiation from retained activity. Standard guidance recommends:
- Maintain three feet of distance from others for three days
- Sleep separately for three days post-treatment
- Avoid close contact with children and pregnant individuals for three days
- No special precautions required for bathroom use or disposal
These straightforward instructions are generally well-tolerated by patients and easy to implement.
Technical Considerations
Dose Calibrator Settings
An important technical detail often overlooked during program setup is that dose calibrator settings differ between Y-90 microsphere products by approximately 10-20%. This variation stems primarily from differences in vial geometry between manufacturers. Programs that use multiple products must establish and validate separate calibration factors for each product, with clear protocols to prevent cross-application of settings.
Spill Response Protocols
Despite best prevention efforts, spills remain a possibility that requires detailed planning. The key principles of Y-90 spill management differ from routine nuclear medicine spill response:
Early Detection: Immediate recognition of contamination events allows for better containment before inadvertent spread. Staff must be trained to remain vigilant throughout the procedure and immediately report any suspected spills or unexpected events during the infusion.
Outside-In Cleanup Approach: Always work from areas of lower contamination toward higher contamination. This prevents tracking contamination to previously clean areas and ensures more effective decontamination.
Proper Waste Sequestration: All cleanup materials must be properly segregated and handled as radioactive waste, with consideration for the extended decay time required.
Conclusion
Successful implementation of a Y-90 microsphere radioembolization program requires attention to the unique characteristics of this therapy that distinguish it from both conventional nuclear medicine procedures and other interventional radiology treatments. The extended half-life, physical properties of microspheres, and delivery setting create specific challenges that must be addressed through careful planning, comprehensive staff training, and robust quality assurance procedures.
By anticipating these challenges and implementing appropriate protocols from program inception, institutions can establish safe, effective Y-90 programs that provide this valuable treatment option while maintaining the highest standards of safety for patients and staff.
Connect with CAMP
Find us on LinkedIn, Facebook, Instagram and Reddit.
Want to learn more about everything it takes to be a medical physicist? CAMP offers a wealth of resources and expertise to help you stay informed and engaged in this dynamic field. Whether you’re a healthcare professional, student, or simply curious about the science behind radiation therapy, CAMP is here to support your journey.
Explore our website to explore our services, discover educational opportunities, and join a community dedicated to advancing medical physics.
